HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

D-JNKI-1

a synthetic, cell permeable peptide that blocks the MAPK-JNK signal pathway; has potential therapeutic value for long-term protection of both the morphological integrity and physiological function of the organ of Corti during times of oxidative stress
Also Known As:
AM 111; AM-111; AM111 peptide; XG 102; XG-102; XG102 peptide
Networked: 29 relevant articles (2 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bonny, Christophe: 7 articles (01/2010 - 03/2006)
2. Ji, Ru-Rong: 5 articles (11/2010 - 03/2006)
3. Gao, Yong-Jing: 4 articles (11/2010 - 04/2009)
4. Combette, Jean-Marc: 3 articles (03/2015 - 09/2010)
5. Behar-Cohen, Francine: 3 articles (03/2015 - 09/2010)
6. Deloche, Catherine: 3 articles (03/2015 - 09/2010)
7. Borsello, Tiziana: 3 articles (01/2015 - 03/2006)
8. Meyer, Thomas: 3 articles (09/2014 - 04/2007)
9. Van De Water, Thomas R: 3 articles (03/2013 - 06/2006)
10. Eshraghi, Adrien A: 3 articles (03/2013 - 06/2006)

Related Diseases

1. Hearing Loss (Hearing Impairment)
2. Ischemia
3. Tinnitus
4. Inflammation
5. Uveitis

Related Drugs and Biologics

1. Prednisolone (Predate)
2. JNK Mitogen-Activated Protein Kinases
3. Neomycin
4. Dextran Sulfate
5. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
6. Oxygen
7. Hyaluronic Acid (Hyaluronan)
8. Glucose (Dextrose)

Related Therapies and Procedures

1. Resuscitation
2. Spinal Injections
3. Cochlear Implantation
4. Ligation
5. Intravenous Injections